Rocket Pharmaceuticals Inc RCKT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
17.47UNCH (UNCH)
Volume
25,939
Close
17.47quote price arrow up+1.04 (+6.33%)
Volume
552,192
52 week range
7.57 - 37.44
Loading...
  • Open16.66
  • Day High17.53
  • Day Low16.50
  • Prev Close16.43
  • 52 Week High37.44
  • 52 Week High Date09/02/21
  • 52 Week Low7.57
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.154B
  • Shares Out66.04M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • YTD % Change-19.97

KEY STATS

  • Open16.66
  • Day High17.53
  • Day Low16.50
  • Prev Close16.43
  • 52 Week High37.44
  • 52 Week High Date09/02/21
  • 52 Week Low7.57
  • 52 Week Low Date05/12/22
  • Market Cap1.154B
  • Shares Out66.04M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • YTD % Change-19.97

RATIOS/PROFITABILITY

  • EPS (TTM)-2.97
  • P/E (TTM)-5.88
  • Fwd P/E (NTM)-5.58
  • EBITDA (TTM)-183.364M
  • ROE (TTM)-43.72%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)5.40%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rocket Pharmaceuticals Inc

Profile

MORE
Rocket Pharmaceuticals, Inc. is a clinical-stage, multi-platform biotechnology company that is focused on the development of gene therapies for rare and devastating diseases. The Company’s clinical-stage ex vivo lentiviral vector (LVV) programs include Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD-I), Danon Disease, Pyruvate Kinase Deficiency (PKD) and Infantile Malignant Osteopetrosis (IMO). FA is a genetic defect in the bone marrow that reduces production of...
Roderick Wong M.D.
Chairman of the Board
Gaurav Shah M.D.
Chief Executive Officer, Director
Kinnari Patel Pharm.D.
President, Chief Operating Officer
John Militello CPA
Interim Principal Financial Officer, Principal Accounting Officer, Vice President - Finance, Senior Controller, Treasurer
Mayo Pujols
Executive Vice President, Chief Technology Officer
Address
350 5th Ave Ste 7530
New York, NY
10118-7501
United States

Top Peers

SYMBOLLASTCHG%CHG
KURA
Kura Oncology Inc
16.23+0.23+1.44%
REPL
Replimune Group Inc
20.27+0.47+2.37%
GOSS
Gossamer Bio Inc
13.87+0.62+4.68%
RYTM
Rhythm Pharmaceuticals Inc
21.80+1.86+9.33%
ERAS
Erasca Inc
9.77+1.30+15.35%